STOCK TITAN

Celldex to Present at Upcoming Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Celldex (NASDAQ:CLDX) said management will participate in three investor conference fireside chats in November and December 2025.

Scheduled events: Guggenheim Healthcare Innovation on Nov 11, 2025 at 10:00 AM ET; Cowen Immunology & Inflammation Summit on Nov 13, 2025 at 9:30 AM ET; and Evercore Healthcare Conference on Dec 2, 2025 at 3:00 PM ET. Live webcasts will be available on the company's Investors > Events & Presentations page, with replays accessible for 90 days after each event.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction 3 Alerts

-1.55% News Effect
+18.0% Peak Tracked
-$24M Valuation Impact
$1.54B Market Cap
4K Volume

On the day this news was published, CLDX declined 1.55%, reflecting a mild negative market reaction. Argus tracked a peak move of +18.0% during that session. Our momentum scanner triggered 3 alerts that day, indicating moderate trading interest and price volatility. This price movement removed approximately $24M from the company's valuation, bringing the market cap to $1.54B at that time.

Data tracked by StockTitan Argus on the day of publication.

HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences:

  • Guggenheim 2nd Annual Healthcare Innovation Conference on Tuesday, November 11 at 10:00 am ET
  • TD Cowen Immunology & Inflammation Summit on Thursday, November 13 at 9:30 am ET
  • 8th Annual Evercore Healthcare Conference on Tuesday, December 2 at 3:00 pm ET

Live webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event.

About Celldex
Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.
Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Meru Advisors
(484) 788-8560
ptill@meruadvisors.com


FAQ

When will Celldex (CLDX) present at the Guggenheim Healthcare Innovation Conference?

Celldex management will present on Nov 11, 2025 at 10:00 AM ET.

How can investors watch Celldex (CLDX) presentations at the Cowen summit on Nov 13, 2025?

Live webcast available on Celldex's Investors > Events & Presentations page, starting Nov 13, 2025 at 9:30 AM ET.

Will Celldex (CLDX) replay the Evercore Healthcare Conference presentation from Dec 2, 2025?

Yes. A replay will be posted on the Investors > Events & Presentations page and available for 90 days after the event.

What dates and times are Celldex (CLDX) scheduled to appear at investor conferences in Nov–Dec 2025?

Scheduled appearances: Nov 11, 2025 10:00 AM ET, Nov 13, 2025 9:30 AM ET, and Dec 2, 2025 3:00 PM ET.

Where on Celldex's website can I find the live webcast and replay for the Nov–Dec 2025 events?

Live webcasts and 90-day replays will be on the company's Investors > Events & Presentations page.
Celldex Therapeutics Inc

NASDAQ:CLDX

CLDX Rankings

CLDX Latest News

CLDX Latest SEC Filings

CLDX Stock Data

1.78B
66.25M
0.19%
111.33%
10.86%
Biotechnology
In Vitro & in Vivo Diagnostic Substances
Link
United States
HAMPTON